Novavax Inc (NASDAQ:NVAX)
| 166.25 Delayed Data As of Oct 18 |  +4.30 / +2.66%Today’s Change | 76.59 Today|||52-Week Range 331.68 | +49.09% Year-to-Date |
Latest NVAX News | Press Releases
| Is Now a Good Time to Buy Ocugen? 11:15am / MotleyFool.com - Paid Partner Content | Why Novavax Stock Is Absurdly Cheap Right Now Oct 14 / MotleyFool.com - Paid Partner Content |
| 5 of the Fastest-Growing Stocks On the Planet Oct 16 / MotleyFool.com - Paid Partner Content | Novavax (NVAX) Concentrates on COVID-19 Vaccine Development Oct 13 / Zacks.com - Paid Partner Content |
| Why Shares of Moderna, Novavax, and Ocugen Are Falling Today Oct 15 / MotleyFool.com - Paid Partner Content | 2 Reasons to Buy Novavax Stock Now and 1 Reason to Skip It Oct 13 / MotleyFool.com - Paid Partner Content |
| Novavax (NVAX) Lags in COVID Vaccine Race: Will It Gather Pace? Oct 15 / Zacks.com - Paid Partner Content | 3 COVID Stocks That Can Turn $1,000 Into $10,000 Oct 12 / MotleyFool.com - Paid Partner Content |
| Pfizer's Next mRNA Vaccine Candidate Goes Beyond COVID-19 Oct 15 / MotleyFool.com - Paid Partner Content | Why Ocugen Stock Is on Fire Today Oct 12 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 161.95 |
| Today’s open | 161.61 |
| Day’s range | 160.56 - 167.89 |
| Volume | 2,634,517 |
| Average volume (3 months) | 4,899,687 |
| Market cap | $12.1B |
Data as of 10/18/2021
Growth & Valuation
| Earnings growth (last year) | -31.99% |
| Earnings growth (this year) | -15.08% |
| Earnings growth (next 5 years) | +2.00% |
| Revenue growth (last year) | +2,448.48% |
| P/E ratio | -- |
| Price/Sales | 13.49 |
| Price/Book | 18.33 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BMRNBiomarin Pharmaceuti... | -1.97 | -2.60% |
| XLRNAcceleron Pharma Inc | +0.06 | +0.03% |
| NBIXNeurocrine Bioscienc... | -0.52 | -0.50% |
| NTLAIntellia Therapeutic... | +0.34 | +0.26% |
Data as of 10/18/2021
Financials
| Next reporting date | November 5, 2021 |
| EPS forecast (this quarter) | -$3.91 |
| Annual revenue (last year) | $475.6M |
| Annual profit (last year) | -$418.3M |
| Net profit margin | -87.94% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Gaithersburg, Maryland |
Forecasts
Chart unavailable
